The Biden administration this week proposed a series of changes aimed at boosting insurance enrollment under the Affordable Care Act, undoing changes made by the Trump administration and adding a few new ones.
Meanwhile, Congress is launching investigations of the Food and Drug Administration’s approval of Aduhelm, a controversial drug to treat Alzheimer’s disease that may or may not be effective in slowing the ailment’s progression. The drug’s pricetag – an estimated $56,000 per year – and the fact that most Alzheimer’s patients are on Medicare mean the federal program could end up footing most of the drug’s bill and threaten the finances of the rest of the health program.
This week’s panelists are Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of The Pink Sheet.
Among the takeaways from this week’s episode:
- The Biden administration’s proposed 2022 rules for the health insurance marketplaces restore some of the policies that were in place before President Donald Trump sought to limit the effects of the Affordable Care Act and create some new ones. Unveiled in the announcement are proposals to lengthen the window for enrollment for everyone by 30 days, provide a special enrollment period each month for low-income people to sign up, and get rid of the requirement that insurers bill separately on premiums for abortion coverage.
- Despite efforts by the new administration to bring down barriers erected by Republicans to ACA coverage, the GOP messaging about the law still is impairing its effectiveness and its popularity. Republicans have argued for 10 years that the federal health law has helped to make health care expensive, and Democrats have had little success changing that depiction, even though health costs were rising quickly years before the law was enacted and helped propel Congress to act. In addition, many people needing insurance don’t know that recent covid relief bills increased premium subsidies to make coverage more affordable and low-income people don’t understand that the federal government provides many subsidies for them to get insurance.
- The increasing number of U.S. cases of the covid delta variant is coming at an awkward time for President Joe Biden, who encouraged people to get vaccinated and set July 4 as a day to celebrate independence from the pandemic.
- Areas of the country where vaccination rates are low are at highest risk of outbreaks of the delta variant. Some of those regions are already seeing problems developing. However, the federal Centers for Disease Control and Prevention has not joined groups like the World Health Organization in calling for a return to masking when indoors.
- Officials have not yet said if Medicare will cover Aduhelm. Generally, Medicare does accept drugs after FDA approval, but many experts think because of the potential cost involved with this medication, Medicare may take a close look at options that include setting eligibility criteria and requiring proof of progress with the drug.
- Walmart announced this week that it will begin selling analogue insulin at low prices for uninsured customers. It is passing along to those people the discounts that are generally given to insurers.
- The e-cigarette company Juul agreed to pay North Carolina $40 million to settle a lawsuit brought by the state alleging that the company that makes vaping products was targeting kids.
Also this week, Rovner interviews Marshall Allen, a reporter for ProPublica, about his new book: “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read too:
Julie Rovner: KQED’s “There’s Only 1 Drug for Postpartum Depression. Why Does Kaiser Permanente Make It So Hard to Get?” by April Dembosky.
Also: KQED’s “She Killed Her Children. Can We Forgive Her?” By April Dembosky.
Kimberly Leonard: Insider’s “Democrats Just Unveiled a $400 Billion Caregiving Bill That Would Supercharge Home Care and Boost Pay for Workers as 820,000 People Wait for Help,” by Kimberly Leonard.
Joanne Kenen: The Incidental Economist’s “Reducing Administrative Costs in US Health Care: Assessing Single Payer and Its Alternatives,” by David Scheinker, Barak Richman, Arnold Milstein, and Kevin Schulman.
Sarah Karlin-Smith: The New York Times’ “’It’s Tough to Get Out’: How Caribbean Medical Schools Fail Their Students,” by Emma Goldberg.
To hear all our podcasts, click here.
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
USE OUR CONTENT
This story can be republished for free (details).